Sexual function and depressive symptoms in young women with elevated macroprolactin content: a pilot study
- PMID: 26902871
- PMCID: PMC4901097
- DOI: 10.1007/s12020-016-0898-5
Sexual function and depressive symptoms in young women with elevated macroprolactin content: a pilot study
Abstract
Elevated prolactin levels seem to be associated with impaired sexuality. The clinical significance of macroprolactinemia, associated with the predominance of high molecular mass circulating forms of prolactin, is still poorly understood. This study was aimed at investigating sexual function in young women with macroprolactinemia. The study enrolled 14 young women with macroprolactinemia, 14 with increased monomeric prolactin levels, as well as 14 age- and weight-matched healthy women. All patients completed a questionnaire evaluating female sexual function (Female Sexual Function Index-FSFI), as well as a questionnaire assessing the presence and severity of depressive symptoms (Beck Depression Inventory Second Edition-BDI-II). Apart from total prolactin levels and macroprolactin content, circulating levels of thyrotropin, total testosterone, and 17-β estradiol were also measured. Patients with elevated monomeric prolactin levels had a lower total FSFI score, as well as lower scores for all domains: sexual desire, sexual arousal, lubrication, orgasm, sexual satisfaction, and dyspareunia. These scores correlated with total and monomeric prolactin levels. In turn, women with macroprolactinemia were characterized by a lower score for sexual desire, and only this score correlated with total prolactin levels and macroprolactin content. The total score in the BDI-II questionnaire was higher in patients with hyper- and macroprolactinemia than in the control subjects. Contrary to multidimensional impairment of sexual function in women with elevated monomeric prolactin, macroprolactinemia only seems to disturb sexual desire.
Keywords: Depressive symptoms; Hyperprolactinemia; Macroprolactin; Polyethylene glycol assay; Prolactin; Sexual functioning.
Figures

Similar articles
-
The effect of bromocriptine treatment on sexual functioning and depressive symptoms in women with mild hyperprolactinemia.Pharmacol Rep. 2018 Apr;70(2):227-232. doi: 10.1016/j.pharep.2017.10.008. Epub 2018 Feb 21. Pharmacol Rep. 2018. PMID: 29475005
-
Importance of macroprolactinemia in hyperprolactinemia.Eur J Obstet Gynecol Reprod Biol. 2014 Dec;183:28-32. doi: 10.1016/j.ejogrb.2014.10.013. Epub 2014 Oct 20. Eur J Obstet Gynecol Reprod Biol. 2014. PMID: 25461348 Review.
-
The association between macroprolactin levels and vitamin D status in premenopausal women with macroprolactinemia: a pilot study.Exp Clin Endocrinol Diabetes. 2015 Sep;123(8):446-50. doi: 10.1055/s-0035-1555877. Epub 2015 Jul 15. Exp Clin Endocrinol Diabetes. 2015. PMID: 26179930 Clinical Trial.
-
Sexual function and depressive symptoms in young women with low vitamin D status: a pilot study.Eur J Obstet Gynecol Reprod Biol. 2016 Sep;204:108-12. doi: 10.1016/j.ejogrb.2016.08.001. Epub 2016 Aug 9. Eur J Obstet Gynecol Reprod Biol. 2016. PMID: 27544743
-
Laboratory and clinical significance of macroprolactinemia in women with hyperprolactinemia.Taiwan J Obstet Gynecol. 2017 Dec;56(6):719-724. doi: 10.1016/j.tjog.2017.10.002. Taiwan J Obstet Gynecol. 2017. PMID: 29241908 Review.
Cited by
-
Sexual dysfunction and associated factors in Behçet's disease: a case-control study.Rheumatol Int. 2024 Oct;44(10):2111-2115. doi: 10.1007/s00296-023-05470-8. Epub 2023 Oct 14. Rheumatol Int. 2024. PMID: 37837448
-
Body self-image disturbances in women with prolactinoma.Braz J Psychiatry. 2020 Jan-Feb;42(1):33-39. doi: 10.1590/1516-4446-2018-0325. Braz J Psychiatry. 2020. PMID: 31314867 Free PMC article.
-
Depression, anxiety, sexual function and quality of life in women with hyperprolactinemia.Rev Bras Ginecol Obstet. 2025 Apr 30;47:e-rbgo7. doi: 10.61622/rbgo/2025rbgo7. eCollection 2025. Rev Bras Ginecol Obstet. 2025. PMID: 40406467 Free PMC article.
-
Low prolactin level identifies hypoactive sexual desire disorder women with a reduced inhibition profile.J Endocrinol Invest. 2023 Dec;46(12):2481-2492. doi: 10.1007/s40618-023-02101-8. Epub 2023 May 18. J Endocrinol Invest. 2023. PMID: 37204690 Free PMC article.
-
The Effect of Metformin on Pituitary Function in Postmenopausal Women with Subclinical Hypothyroidism and Macroprolactinemia: A Single-Center Prospective Case-Control Study.Pharmaceuticals (Basel). 2025 Jun 2;18(6):834. doi: 10.3390/ph18060834. Pharmaceuticals (Basel). 2025. PMID: 40573230 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical